Adiponectin concentration in plasma is associated with muscle fiber size in healthy middle-aged men

References

• Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr 2002;22:325–46.
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010; 47:62–79.
   Google Scholar
• Kokta TA, Dodson MV, Gertler A, Hill RA. Intercellular signaling between adipose tissue and muscle tissue. Domest Anim Endocrinol 2004;27:303–31.
   PubMed Web of Science ®Google Scholar
• Malenfant P, Joanisse DR, Theriault R, Goodpaster BH, Kelley DE, Simoneau JA. Fat content in individual muscle fibers of lean and obese subjects. Int J Obes Relat Metab Disord 2001;25:1316–21.
   PubMed Web of Science ®Google Scholar
• Scott W, Stevens J, Binder-Macleod SA. Human skeletal muscle fiber type classifications. Phys Ther 2001;81: 1810–6.
   PubMed Web of Science ®Google Scholar
• Zierath JR, Hawley JA. Skeletal muscle fiber type: influence on contractile and metabolic properties. Plos Biol 2004; 2:e348.
   PubMed Web of Science ®Google Scholar
• Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987;80:415–24.
   PubMed Web of Science ®Google Scholar
• Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, Cunningham PR, Swanson MS, Houmard JA. Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 2002;282:E1191–6.
   PubMed Web of Science ®Google Scholar
• Gerrits MF, Ghosh S, Kavaslar N, Hill B, Tour A, Seifert EL, Beauchamp B, Gorman S, Stuart J, Dent R, McPherson R, Harper ME. Distinct skeletal muscle fiber characteristics and gene expression in diet-sensitive versus diet-resistant obesity. J Lipid Res 2010;51:2394–404.
   PubMedGoogle Scholar
• Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ. Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm 2009;831670–8.
   PubMedGoogle Scholar
• Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004;145:5589–97.
   PubMed Web of Science ®Google Scholar
• Godoy-Matos AF, Bahia LR, Domingues RC, Sicuro F, Tambascia M, Geloneze B, Kraemer-Aguiar LG, Bouskela E. Adiponectin is related to intramyocellular lipid content in non-diabetic adults. J Endocrinol Invest 2010;33:382–7.
   PubMedGoogle Scholar
• Kantartzis K, Staiger H, Machann J, Schick F, Claussen CD, Machicao F, Fritsche A, Haring HU, Stefan N. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans. Obesity 2009;17:390–2.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Arnlov J, Zethelius B, Vasan RS, Flyvbjerg A, Frystyk J, Berne C, Hanni A, Lind L, Sundstrom J. Associations of serum adiponectin with skeletal muscle morphology and insulin sensitivity. J Clin Endocrinol Metab 2009;94: 953–7.
   PubMedGoogle Scholar
• Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K. Role of adipokines in complications related to obesity: a review. Adv Med Sci 2009;54:150–7.
   PubMed Web of Science ®Google Scholar
• Stofkova A. Resistin and visfatin: regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 2010;44: 25–36.
   PubMedGoogle Scholar
• Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511–25.
   PubMed Web of Science ®Google Scholar
• Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003;52:2546–53.
   PubMed Web of Science ®Google Scholar
• Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010;106: 56–61.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784–92.
   PubMed Web of Science ®Google Scholar
• Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV, Harrington LM, Miller KK. Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women. Obesity 2011;19: 911–6.
   PubMedGoogle Scholar
• Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2 +) and AMPK/SIRT1. Nature 2010;464:1313–9.
   PubMed Web of Science ®Google Scholar
• Turpeinen JP, Leppavuori J, Heinonen OJ, Kaila K, Salo J, Lilja M, Kesaniemi YA. Muscle fiber type I influences lipid oxidation during low-intensity exercise in moderately active middle-aged men. Scand J Med Sci Sports 2006;16: 134–40.
   PubMedGoogle Scholar
• Ukkola O, Poykko S, Paivansalo M, Kesaniemi YA. Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis. Ann Med 2008;40: 465–73.
   PubMed Web of Science ®Google Scholar
• Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999;245:163–74.
   PubMed Web of Science ®Google Scholar
• Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77–97.
   PubMed Web of Science ®Google Scholar
• Santaniemi M, Kesaniemi YA, Ukkola O. Low plasma adiponectin concentration is an indicator of the metabolic syndrome. Eur J Endocrinol 2006;155:745–50.
   PubMed Web of Science ®Google Scholar
• Pisto P, Ukkola O, Santaniemi M, Kesaniemi YA. Plasma adiponectin – an independent indicator of liver fat accumulation. Metabolism 2011; 60:1515–20.
   PubMed Web of Science ®Google Scholar
• Kunnari A, Ukkola O, Paivansalo M, Kesaniemi YA. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 2006;91:2755–60.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85: 2402–10.
   PubMed Web of Science ®Google Scholar
• Dubowitz V, Brooke M, Neville H. Muscle biopsy: a modern approach. London: Saunders WB Co., 1973.
   Google Scholar
• Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol 2000;89:81–8.
   PubMed Web of Science ®Google Scholar
• Stefanyk LE, Dyck DJ. The interaction between adipokines, diet and exercise on muscle insulin sensitivity. Curr Opin Clin Nutr Metab Care 2010;13:255–9.
   PubMed Web of Science ®Google Scholar
• Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Ateroscler Thromb 2010;17:332–41.
   PubMed Web of Science ®Google Scholar
• Gavin TP, Stallings HW, 3rd, Zwetsloot KA, Westerkamp LM, Ryan NA, Moore RA, Pofahl WE, Hickner RC. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans. J Appl Physiol 2005;98:315–21.
   PubMed Web of Science ®Google Scholar
• Thompson LV. Effects of age and training on skeletal muscle physiology and performance. Phys Ther 1994;74:71–81.
   PubMed Web of Science ®Google Scholar
• Nawrocki AR, Scherer PE. The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Paharmacol 2004;4: 281–9.
   PubMed Web of Science ®Google Scholar
• Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, Mandarino L, Ravussin E, Smith SR. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 2006;4:75–87.
   PubMed Web of Science ®Google Scholar
• Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L. Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation. J Clin Endocrinol Metab 2007;92:4883–8.
   PubMed Web of Science ®Google Scholar
• Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, Berria R, Belfort R, DeFronzo RA, Mandarino LJ, Ravussin E. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004;47:816–20.
   PubMed Web of Science ®Google Scholar
• Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, Kamon J, Kobayashi M, Suzuki R, Hara K, Kubota N, Terauchi Y, Froguel P, Nakae J, Kasuga M, Accili D, Tobe K, Ueki K, Nagai R, Kadowaki T. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 2004;279: 30817–22.
   PubMed Web of Science ®Google Scholar
• Lara-Castro C, Garvey WT. Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 2008;37:841–56.
   PubMedGoogle Scholar
• Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86 :3815–9.
   PubMed Web of Science ®Google Scholar
• Arawaka N, Daimon M, Oizumi T, Jimbu Y, Kameda W, Yamaguchi H, Ohnuma H, Tominaga M, Kato T. Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population – the Funagata study. Metabolism 2006;55:324–30.
   PubMed Web of Science ®Google Scholar
• Bennett NR, Boyne MS, Cooper RS, Royal-Thomas TY, Bennett FI, Luke A, Wilks RJ, Forrester TE. Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change. Clin Endocrinol (Oxf) 2009;70:408–14.
   PubMedGoogle Scholar
• Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond) 2010;34: 852–8.
   PubMed Web of Science ®Google Scholar
• Malenfant P, Tremblay A, Doucet E, Imbeault P, Simoneau JA, Joanisse DR. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 2001;280: E632–9.
   Google Scholar
• van Herpen NA, Schrauwen-Hinderling VB, Schaart G, Mensink RP, Schrauwen P. Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 2011;96:691–5.
   Google Scholar
• Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459–69.
   PubMed Web of Science ®Google Scholar